Teva Pharmaceutical Industries
TEVA
$7.23
Share price
0.42%
Change (1 day)
-24.05%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - Total debt
Total debt on the balance sheet as of December 2022 : $21.56 B
According to Teva Pharmaceutical Industries's latest financial reports the company's total debt is $21.56 B. A company’s total debt is the sum of all current and non-current debts.
Teva Pharmaceutical Industries - Total debt on balance sheet (from 2001 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $21.56 B | -8.09% |
| 2021-12-31 | $23.45 B | -11.13% |
| 2020-12-31 | $26.39 B | -3.45% |
| 2019-12-31 | $27.34 B | -5.44% |
| 2018-12-31 | $28.91 B | -10.96% |
| 2017-12-31 | $32.47 B | -9.29% |
| 2016-12-31 | $35.80 B | 259.15% |
| 2015-12-31 | $9.96 B | -3.48% |
| 2014-12-31 | $10.32 B | -15.29% |
| 2013-12-31 | $12.19 B | -17.17% |
| 2012-12-31 | $14.71 B | 1.39% |
| 2011-12-31 | $14.51 B | 110.96% |
| 2010-12-31 | $6.88 B | 22.61% |
| 2009-12-31 | $5.61 B | -33.53% |
| 2008-12-31 | $8.44 B | 62.74% |
| 2007-12-31 | $5.18 B | -2.61% |
| 2006-12-31 | $5.32 B | 147.91% |
| 2005-12-31 | $2.14 B | 3.62% |
| 2004-12-31 | $2.07 B | 42.08% |
| 2003-12-31 | $1.45 B | -23.17% |
| 2002-12-31 | $1.89 B | 30.72% |
| 2001-12-31 | $1.45 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $29.20 B | 35.45% | 🇨🇭 Switzerland |
 Pfizer PFE | $34.87 B | 61.73% | 🇺🇸 USA |
 Sanofi SNY | $22.71 B | 5.36% | 🇫🇷 France |
 Merck MRK | $30.69 B | 42.34% | 🇺🇸 USA |
 AstraZeneca AZN | $31.50 B | 46.11% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $25.89 B | 20.10% | 🇬🇧 UK |
 Dr. Reddy's RDY | $0.21 B | -99.02% | 🇮🇳 India |